Lu-177 as SOC vs Clinical Trial
Since I've now just had my 16th cabazitazel/carboplatin chemo treatment, we're looking at options and working on Lu-177.
I'm curious that, since Lu-177 is now FDA approved and is Standard Of Care, is there an advantage to seeking a clinical trial vs receiving it as SOC?
Since I've now just had my 16th cabazitazel/carboplatin chemo treatment, we're looking at options and working on Lu-177.
I'm curious that, since Lu-177 is now FDA approved and is Standard Of Care, is there an advantage to seeking a clinical trial vs receiving it as SOC?